Next-Generation Sequencing The latest news on next-generation sequencing. Jan 19, 2023 Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug Jan 4, 2023 Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements Premium Dec 29, 2022 Study Shows Potential of Drug Sensitivity Profiling With Sequencing for Pediatric Cancers Dec 15, 2022 Leukemia Patients See Survival Benefit With Integrated Functional Drug, Molecular Testing Approach Premium Dec 8, 2022 Adding Ibrance to Fulvestrant Doesn't Benefit CDK4/6 Inhibitor-Refractory Breast Cancer Patients Premium Nov 30, 2022 Bladder Cancer Genomic Landscape Study Aims to Engender New Biomarker-Guided Therapies Premium Nov 17, 2022 Biomarker Predicts Immunotherapy Benefit in Head and Neck Cancer but Commercial Path Unclear Premium Nov 16, 2022 Genome Insight, Seoul National University Hospital Collaborate on WGS Study of Pediatric Cancer Dx Nov 10, 2022 Diaceutics, PMC Identify Ways Lung Cancer Patients Are Losing Out on Precision Oncology Therapies Premium Nov 7, 2022 Industry Coalitions Push for Wider Coverage, More Awareness of Comprehensive Genomic Profiling Premium Nov 7, 2022 A2 Bio Expects to Begin Phase I Trials of its CAR T-Cell Therapies in 2023 Oct 5, 2022 Genomic Test IDs Pancreatic Cysts Likely to Progress to Cancer Better Than Standard Guidelines Premium Oct 3, 2022 Highmark Asks Labs for Additional Validation Data on Cancer NGS Tests; Will Other Insurers Follow? Premium Sep 21, 2022 Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib Sep 21, 2022 Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients Sep 14, 2022 Biomarker Test Access for Precision Oncology Varies Widely in Europe, ESMO Survey Finds Premium Sep 11, 2022 Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Sep 8, 2022 OncXerna Begins Navicixizumab Phase II Basket Trial Aug 24, 2022 Myriad Genetics, Clarified Precision Medicine Team up on Molecular Tumor Board Service Aug 12, 2022 AstraZeneca, Daiichi Sankyo's Enhertu Scores FDA Accelerated Approval in HER2-Mutant Lung Cancer Load More Breaking News Ratio Therapeutics Raises $20M in Series A Financing Guardant Health, AnHeart Tx to Develop Blood- and Tissue-Based CDx for NSCLC Drug Ellipses Pharma Cleared by FDA to Open Phase I/II AML Trial Survey Reveals Changing Genetic Testing Patterns, Persistent Disparities in Precision Oncology Amgen's Lumakras Sales Increased 58 Percent in Q4 2022 Coeptis Therapeutics, University of Pittsburgh Studying SNAP-CAR Therapy in HER2-Positive Cancers
